Alvocidib companion diagnostic - Eutropics/Tolero PharmaceuticalsAlternative Names: Praedicare DxTM
Latest Information Update: 28 Dec 2016
At a glance
- Originator Eutropics Pharmaceuticals
- Developer Eutropics Pharmaceuticals; Tolero Pharmaceuticals
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Acute myeloid leukaemia; Chronic lymphocytic leukaemia
- Preclinical Myelodysplastic syndromes